The Female Health Company Receives USAID | DELIVER PROJECT Order for 6.1 Million Units
February 28 2008 - 7:30AM
PR Newswire (US)
CHICAGO, Feb. 28 /PRNewswire-FirstCall/ -- The Female Health
Company (AMEX:FHC) announced it has received an order from John
Snow, Inc., which implements the USAID | DELIVER PROJECT, for the
delivery of 6.1 million female condoms (FC) for the United States
Agency for International Development (USAID) programs. For many
years, USAID has been among the largest international donors of
contraceptives and condoms. The Agency developed an operational
plan for its HIV/AIDS "expanded response" strategy, which includes
the establishment of the Commodity Fund (CF) to centrally-finance
male and female condoms for HIV/AIDS programs and to ensure their
expedited delivery to countries. Through the Commodity Fund, which
began in 2002, USAID provides male and female condoms to Missions
for HIV/AIDS prevention activities. O. B. Parrish, Chairman and CEO
of FHC, praised USAID actions stating, "In continuing female condom
procurement in 2008, USAID is demonstrating its commitment to
supporting HIV/AIDS prevention efforts around the World. This
commitment is particularly critical as the Global Community
recognizes the increasing numbers of females affected by AIDS."
UNAIDS reports that worldwide, 33.2 million people, 15.4 million of
which are women aged 15 years and older are now living with HIV.
The Global Coalition on Women and AIDS, a UNAIDS Initiative, is
calling for more money in AIDS programs that work for women
including closing the funding gap for the female condom and
microbicides development." About The Female Health Company, Inc.
The Female Health Company, based in Chicago, Illinois, manufactures
and markets the FC Female Condom(R), which is primarily distributed
by public health organizations and donor groups in over 90
developing countries around the world. World-wide, the Female
Condom is available in various programs in 108 countries. The
Company owns certain worldwide rights to the FC Female Condom(R),
including patents that have been issued in the United States,
United Kingdom, Japan, France, Italy, Germany, Spain, the European
Patent Convention, the People's Republic of China, Canada, South
Korea and Australia. FC Female Condom(R) is the only available
FDA-approved product controlled by a woman that offers dual
protection against sexually transmitted diseases, including
HIV/AIDS, and unintended pregnancy. For more information about the
Female Health Company, visit the Company's web site at
http://www.femalehealth.com/ or http://www.femalecondom.org/. "Safe
Harbor" statement under the Private Securities Litigation Reform
Action of 1995: The statements in this release which are not
historical fact are forward-looking statements based upon the
Company's current plan and strategies, and reflect the Company's
current assessment of the risks and uncertainties related to its
business, including such things as product demand and market
acceptance; the economic and business environment and the impact of
government pressures; currency risks; capacity; efficiency and
supply constraints; and other risks detailed in the Company's press
releases, shareholder communication and Securities and Exchange
Commission filings. Actual events affecting the Company and the
impact of such events on the Company's operations may vary from
those currently anticipated. DATASOURCE: The Female Health Company,
Inc. CONTACT: Investors, William R. Gargiulo, Jr., +1-231-526-1244,
or Donna Felch, +1-312-595-9742, both of The Female Health Company,
Inc. Web site: http://www.femalehealth.com/
http://www.femalecondom.org/
Copyright
Focus Morningstar Health Care Index Etf (AMEX:FHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Focus Morningstar Health Care Index Etf (AMEX:FHC)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Focus Morningstar Health Care Index Etf (American Stock Exchange): 0 recent articles
More The Female Health Company News Articles